US FDA applications for nicotine pouches like Zyn and Velo delayed despite fast-track scheme amid concerns over risks to non-users and kids, according to reports
Context
The delay in FDA applications for nicotine pouches like Zyn and Velo highlights significant regulatory hurdles amid safety concerns regarding non-users and children. This could dampen market sentiment for companies involved in this sector, as prolonged uncertainty may affect product launches and sales forecasts, influencing stock prices and potential investment in related equities.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#PM.US#FDA#EU SESSION#US SESSION#US EQUITIES